We discovered that miR-490-5p mimic weakened the malignant phenotype of pancreatic cancer through regulating EMT via attenuating MAGI2-AS3, which offered a new entry point to the therapy of pancreatic cancer. The gene discussed is MAGI2; the disease is familial pancreatic carcinoma.